Martina Ardito

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 16, 2026

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 01, 2026

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models.

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models.

Journal: Cells

Published: April 29, 2026

Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs.

Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 14, 2025

Exosomes and immune modulation: implications for neuroblastoma immunotherapy.

Exosomes and immune modulation: implications for neuroblastoma immunotherapy.

Journal: Frontiers in immunology

Published: March 25, 2025

The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism.

The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 18, 2024

Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation.

Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation.

Journal: The oncologist

Published: August 09, 2024

Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.

Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing.

Journal: HLA

Published: January 15, 2024

Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients.

Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients.

Journal: Cells

Published: June 01, 2023

Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.

Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.

Journal: EBioMedicine

Published: August 08, 2022

Biomechanics of cultured hepatic cells during different steatogenic hits.

Biomechanics of cultured hepatic cells during different steatogenic hits.

Journal: Journal of the mechanical behavior of biomedical materials

Published: December 10, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026